ZENITH EPIGENETICS LTD has a total of 64 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are ZENITH EPIGENETICS CORP, IMPACT BIOMEDICINES INC and NUMEDICUS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | Canada | 8 | |
#4 | Australia | 7 | |
#5 | Taiwan | 5 | |
#6 | WIPO (World Intellectual Property Organization) | 5 | |
#7 | Japan | 3 | |
#8 | Israel | 2 | |
#9 | South Africa | 2 | |
#10 | EAPO (Eurasian Patent Organization) | 1 | |
#11 | Hong Kong | 1 | |
#12 | Hungary | 1 | |
#13 | Mexico | 1 | |
#14 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Biotechnology | |
#7 | Chemical engineering | |
#8 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Liu Shuang | 31 |
#2 | Quinn John Frederick | 30 |
#3 | Wang Ruifang | 29 |
#4 | Duffy Bryan Cordell | 28 |
#5 | Jiang May Xiaowu | 25 |
#6 | Young Peter Ronald | 24 |
#7 | Wagner Gregory Steven | 23 |
#8 | Martin Gregory Scott | 20 |
#9 | Campeau Eric | 10 |
#10 | Kharenko Olesya | 10 |
Publication | Filing date | Title |
---|---|---|
TW202024078A | Method of manufacturing a solid form of a bet bromodomain inhibitor | |
TW202017926A | Combination therapy for the treatment of prostate cancer | |
TW202035401A | Solid forms of a bet inhibitor | |
TW202023552A | Combination therapy for the treatment of estrogen-receptor positive breast cancer | |
TW202027746A | Combination therapy for the treatment of triple-negative breast cancer | |
CA3007168A1 | 1h-imidazo[4,5-b]pyridinyl and 2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridinyl heterocyclic bet bromodomain inhibitors | |
EP3227280A1 | Substituted pyridines as bromodomain inhibitors | |
US2017320866A1 | Substituted pyridinones as bromodomain inhibitors | |
EP3010918A2 | Novel substituted bicyclic compounds as bromodomain inhibitors | |
EP3010503A2 | Novel bicyclic bromodomain inhibitors |